Management of Cardiovascular Risk in Patients with Chronic Inflammatory Diseases: Current Evidence and Future

Jesper Lindhardsen1, Søren Lund Kristensen2, Ole Ahlehoff3

  • 1Department of Internal Medicine, Copenhagen University Hospital Slagelse, 4200, Slagelse, Denmark.

Insights

Patients with chronic inflammatory diseases (CID) face higher cardiovascular disease (CVD) risks. Research explores inflammation inhibition for CVD prevention and improved patient management strategies.

Area of Science:

  • Cardiology
  • Rheumatology
  • Immunology

Background:

  • Chronic inflammatory diseases (CID) like rheumatoid arthritis, psoriasis, inflammatory bowel diseases, and systemic lupus erythematosus are linked to increased cardiovascular disease (CVD) risk.
  • This association contributes to reduced life expectancy in affected patients, necessitating focused research and clinical attention.

Purpose of the Study:

  • To review the evidence connecting CIDs and CVD.
  • To discuss current cardiovascular risk management recommendations for patients with CID.
  • To explore future research directions and potential interventions for CVD prevention in this population.

Main Methods:

  • Literature review of existing studies on CID and CVD.
  • Analysis of current cardiovascular risk management guidelines.
  • Discussion of ongoing and planned clinical trials.

Main Results:

  • A significant association exists between chronic inflammation and heightened CVD risk.
  • Current management strategies require adaptation for CID patients.
  • Inhibiting inflammation is a promising therapeutic avenue for CVD prevention.

Conclusions:

  • There is a clear need for multidisciplinary approaches and specialized guidelines for CVD prevention in patients with CID.
  • Targeting inflammation holds potential for improving cardiovascular outcomes in these individuals.
  • Further research and clinical trials are crucial to refine prevention and treatment strategies.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
589
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
500
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
453
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
361
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
583
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
574